101 results on '"Gargallo, M."'
Search Results
2. Evaluation of new chlorhexidineand cetylpyridinium chloride-based mouthrinse formulations adjunctive to scaling and root planing: pilot study
- Author
-
García-Gargallo, M, Zurlohe, Martina, Montero Solís, Eduardo, Alonso Álvarez, Bettina María, Serrano, Jorge, Sanz Alonso, Mariano, Herrera González, David, García-Gargallo, M, Zurlohe, Martina, Montero Solís, Eduardo, Alonso Álvarez, Bettina María, Serrano, Jorge, Sanz Alonso, Mariano, and Herrera González, David
- Abstract
Objective: To compare the effect of two newly formulated chlorhexidine (CHX) and cetylpyridinium chloride (CPC) mouthrinses after scaling and root planing (SRP) in terms of clinical, microbiological, patient-based variables and adverse events, with a positive control with the same active components, already marketed and tested. Methods: A pilot, randomized clinical trial, double-blind, parallel design with 1-month follow-up was conducted. Chronic periodontitis patients requiring non-surgical periodontal therapy were enrolled and randomly assigned to: (i) SRP and test-1 (new reformulation: 0.12% CHX and 0.05% CPC); (ii) SRP and test-2 (new formulation: 0.03% CHX and 0.05% CPC); or (iii) SRP and positive control (commercial product: 0.12% CHX and 0.05% CPC). All variables were evaluated at baseline and 1 month after SRP. Quantitative variables were compared by means of anova or Kruskal-Wallis test and qualitative variables by chi-square or McNemar tests. Results: Thirty patients (10 per group) were included. After 1 month, there were significant differences among groups in plaque levels (P = 0.016) as test-1 showed less sites with plaque than test-2 (31.15% [standard error-SE 2.21%] versus 49.39% [SE 4.60%), respectively). No significant differences were found for global patient perception of the product or in adverse effects. Test groups showed better results in levels and proportions (P = 0.022) of Capnocytophaga spp. Conclusions: Within the limitations of this pilot study, it can be concluded that the newly formulated 0.12% CHX and 0.05% CPC mouthrinse showed larger plaque level reductions, without showing more adverse effects, when compared to the other two mouthrinses, after SRP., This study was supported by Dentaid (Cerdanyola del Vall es, Barcelona, Spain) through a grant to the ETEP Research Group, Depto. de Especialidades Clínicas Odontológicas, Fac. de Odontología, TRUE, pub
- Published
- 2024
3. PERSISTING SYMPTOMS IN A COHORT OF 1966 SUBJECTS WITH SARS-COV-2 INFECTION: 1 YEAR FOLLOW-UP
- Author
-
Caguana Vélez, O A, primary, Cumpli Gargallo, M C, additional, Comas serrano, M, additional, Posso Rivera, M, additional, Duran Jordà, X, additional, Balcells Vilarnau, E, additional, Admetllo Papiol, M, additional, Herranz Blasco, A, additional, Villar Garcia, J, additional, and Badenes Bonet, D, additional
- Published
- 2022
- Full Text
- View/download PDF
4. Evaluation of new chlorhexidine‐ and cetylpyridinium chloride‐based mouthrinse formulations adjunctive to scaling and root planing: pilot study
- Author
-
García‐Gargallo, M, Zurlohe, M, Montero, E, Alonso, B, Serrano, J, Sanz, M, and Herrera, D
- Published
- 2017
- Full Text
- View/download PDF
5. RISK score for developing ventilator-associated pneumonia in children: The RISVAP study
- Author
-
Girona-Alarcón M, Bobillo-Perez S, Solé-Ribalta A, Cuadras D, Guitart C, Balaguer-Gargallo M, Cambra FJ, and Jordán-García I
- Subjects
ventilator-associated pneumonia ,pediatrics ,healthcare-associated infection ,intensive care - Abstract
OBJECTIVES: Ventilator-associated pneumonia (VAP) is the second most common healthcare-associated infection in children. The aim of this study was to determine the risk factors for VAP in children and to create a risk score for developing VAP (RISVAP score). STUDY DESIGN: It was a prospective observational study, including children who required mechanical ventilation (MV), registered in the multicentre ENVIN-HELICS database from 2014 to 2019. The regression coefficients of each independent risk factor for VAP were used to create the RISVAP score. Each factor scored 0 if it was absent, or, if it was present, an assigned value from 1 to 7, according to the regression coefficient. RESULTS: A total of 3798 patients were included, 97(2.5%) developing VAP. The independent risk factors for VAP were: female (odds ratio [OR]: 1.642, p = 0.024), MV > 4 days (OR: 26.79, p < 0.001), length in pediatric intensive care unit > 7 days (OR: 11.74, p < 0.001), and previous colonisation (OR: 4.18, p < 0.001). The RISVAP was calculated for each patient as the sum of all the independent risk factors. Three risk groups were obtained: low (0-5 points), intermediate (6-12 points), and high risk for VAP (13-16 points). The area under the curve for the final score was 0.905 (95%confidence interval: 0.888-0.923, p < 0.001). CONCLUSIONS: The RISVAP is the first risk score for VAP in pediatric populations. Using this predictive score, might be helpful to detect vulnerable patients and therefore implement preventative strategies.
- Published
- 2022
6. Outcomes for paediatric acute leukaemia patients admitted to the paediatric intensive care unit
- Author
-
Marina Caballero Bellón, Anna Faura Faura, Margarit A, Bobillo-Perez S, Català-Temprano A, Alonso-Saladrigues A, Conde Cuevas N, Balaguer-Gargallo M, Rives-Sola S, and Jordán-García I
- Subjects
Critical care outcomes ,Sepsis ,Leukaemia ,Paediatric intensive care units ,Lymphoid - Abstract
Children with acute leukaemia (AL) are a high-risk population for infections and life-threatening conditions requiring paediatric intensive care unit (PICU) admission, presenting an increased mortality rate. A few literature exists about PICU outcomes in this kind of patients, especially with haematopoietic stem cell transplant (HSCT) background. We investigated the clinical and epidemiological characteristics of these patients as well as their outcomes. A retrospective, single-centre analytical/observational study was conducted from January 2011 to December 2018 in the PICU of a tertiary care hospital. AL patients from 28 days to 18 years old admitted to the PICU were included, excluding those with histories of HSCT or CAR T-cell therapy. We collected epidemiological and clinical characteristics, laboratory and microbiology results and outcomes. Forty-three patients with AL required urgent admission (35 lymphoblastic and 8 myeloblastic) for 63 different episodes. The main reasons were sepsis (21, 33.3%), hyperleukocytosis (12, 19%), respiratory failure (11, 17.5%) and seizures (8, 12.7%). Nineteen (30.2%) required inotropic support, and fifteen (23.8%) required mechanical ventilation. Three patients died at the hospital (3/43, 6.9%). Sixty-day mortality was 9.3%, and 1-year mortality was 13.9%. There was no differences regarding the type of AL and 60-day mortality (log-rank 2.652, p = 0.103).Conclusion: In our study, the main cause of admission for AL patients was infection, which was associated to more severity and longer hospital admission. What is Known: • Acute leukaemia is the most common childhood cancer. Admission to a paediatric intensive care unit is required in 30% of children with acute leukaemia. • Regarding the outcomes of children with acute leukaemia that require admission to the intensive care unit data are scarce. What is New: • Mortality in acute leukaemia patients admitted to the paediatric intensive care unit is lower than that of patients with a history of stem cell therapy but higher than that of patients with solid tumours. • The main reason for admission was sepsis, which is related in literature to more severity and long length of stay.
- Published
- 2022
7. New multivariable prediction model PEdiatric SEpsis recognition and stratification (PESERS score) shows excellent discriminatory capacity
- Author
-
Solé-Ribalta A, Launes-Montana C, Felipe-Villalobos A, Balaguer-Gargallo M, Luaces-Cubells C, Roser Garrido Romero, Bobillo-Perez S, Girona M, Valls-Lafon A, Cambra-Lasaosa FJ, Esteban-Torne E, and Jordán-García I
- Subjects
prediction model ,sepsis ,paediatric ,stratification ,biomarkers ,infection - Abstract
Aim To develop a quantitative predictive scoring model for the early recognition and assessment of paediatric sepsis. Methods Prospective observational study including emergency department and in-hospital febrile patients under 18 years. Sepsis diagnose (Goldstein 2005 definitions) was the main outcome. Variables associated with the outcome were included in a multivariable analysis. Cut-off points, odds ratio and coefficients for the variables kept after the multivariable analysis were identified. The score was obtained from the coefficients, The AUC was obtained from ROC-analysis, and internal validation was performed using k-fold cross-validation. Results The analysis included 210 patients. 45 variables were evaluated and the bivariate analysis identified 24 variables associated with the outcome. After the multivariable regression, 11 variables were kept and the score was obtained. The model yielded an excellent AUC of 0.886 (95% CI 0.845-0.927), p < 0.001 for sepsis recognition. With a cut-off value of 5 for the score, we obtained a sensitivity of 98%, specificity of 76.7%, positive predictive value of 87.9% and negative predictive value of 93.3%. Conclusion The proposed scoring model for paediatric sepsis showed adequate discriminatory capacity and sufficient accuracy, which is of great clinical significance in detecting sepsis early and predicting its severity. Nevertheless external validation is needed before clinical use.
- Published
- 2022
8. Risk factors and incidence of invasive bacterial infection in severe bronchiolitis: the RICOIB prospective study
- Author
-
Guitart C, Alejandre-Galobardes C, Bobillo-Perez S, Girona M, Solé-Ribalta A, Cambra-Lasaosa FJ, Balaguer-Gargallo M, and Jordán-García I
- Subjects
Risk Factors ,Bronchiolitis ,Viral ,Bacterial Infections ,Outcomes - Abstract
Background Bacterial infection (BI), both community-acquired (CA-BI) and hospital-acquired (HAI), might present as a severe complication in patients with bronchiolitis. This study aimed to describe BI in children with severe bronchiolitis, and to define risk factors for BI. Methods This was a prospective, descriptive study that included infants admitted to the pediatric intensive care unit (PICU) due to bronchiolitis between 2011 and 2017. The BROSJOD score was calculated to rate the severity of bronchiolitis. Results Inclusion of 675 patients, with a median age of 47 days (IQR 25-99). 175 (25.9%) patients developed BI, considered HAI in 36 (20.6%). Patients with BI had higher BROSJOD score, PRISM III, and required invasive mechanical ventilation and inotropic support more frequently (p < 0.001). BI was independently associated with BROSJOD higher than 12 (OR 2.092, 95%CI 1.168-3.748) CA-BI was associated to BROSJOD > 12 (OR 2.435, 95%CI 1.379-4.297) and bacterial co-infection (OR 2.294 95%CI 1.051-5.008). Concerning HAI, an independent association was shown with mechanical ventilation longer than 7 days (OR 5.139 95%CI 1.802-14.652). Infants with BI had longer PICU and hospital stay (p < 0.001), Mortality was higher in patients with HAI. Conclusions A quarter of infants with severe bronchiolitis developed BI. A BROSJOD > 12 may alert the presence of CA-BI, especially pneumonia. Patients with BI have higher morbidity and mortality.
- Published
- 2022
9. Bronchiolitis, epidemiological changes during the SARS-CoV-2 pandemic
- Author
-
Guitart C, Bobillo-Perez S, Alejandre-Galobardes C, Armero-Campos G, Launes-Montana C, Cambra-Lasaosa FJ, Balaguer-Gargallo M, and Jordán-García I
- Subjects
Pandemic ,SARS-CoV-2 ,Bronchiolitis ,Non-pharmaceutical interventions (NPIs) - Abstract
Background: Bronchiolitis is the most common viral infection of the lower respiratory tract in infants under 2 years of age. The aim of this study was to analyze and compare the seasonal bronchiolitis peaks before and during the SARS-CoV-2 pandemic. Methods: Descriptive, prospective, and observational study. Patients with severe bronchiolitis admitted to the Pediatric Intensive Care Unit (PICU) of a referral tertiary hospital between September 2010 and June 2021 were included. Demographic data were collected. Viral laboratory-confirmation was carried out. Each season was analyzed and compared. The daily average temperature was collected. Results: 1116 patients were recruited, 58.2% of them males. The median age was 49 days. Respiratory syncytial virus (RSV) was isolated in 782 cases (70.1%). In April 2021, the first and only case of bronchiolitis caused by SARS-CoV-2 was identified. The pre- and post-pandemic periods were compared. There were statistically significant differences regarding: age, 47 vs. 73 days (p = 0.006), PICU and hospital length of stay (p = 0.024 and p = 0.001, respectively), and etiology (p = 0.031). The peak for bronchiolitis in 2020 was non-existent before week 52. A delayed peak was seen around week 26/2021. The mean temperature during the epidemic peak was 10 degrees C for the years of the last decade and is 23 degrees C for the present season. Conclusion: The COVID-19 pandemic outbreak has led to a clearly observable epidemiological change regarding acute bronchiolitis, which should be studied in detail. The influence of the environmental temperature does not seem to determine the viral circulation.
- Published
- 2022
10. Acute Leukemia Patients in the PICU: Prognostic Factors and Mortality
- Author
-
Marina Caballero Bellón, Anna Faura Faura, Bobillo-Perez S, Soler, AM, Balaguer-Gargallo M, Conde Cuevas N, Català-Temprano A, Rives-Sola S, and Jordán-García I
- Published
- 2021
11. Lung ultrasound findings in pediatric patients with COVID-19
- Author
-
Guitart C, Suárez R, Girona M, Bobillo-Perez S, Hernandez-Platero L, Balaguer-Gargallo M, Cambra-Lasaosa FJ, Jordán-García I, and KIDS-Corona study group, Kids Corona Platform
- Subjects
Lung ultrasound ,COVID-19 ,Pneumonia ,Pediatrics - Abstract
During the pandemic caused by the novel coronavirus (COVID-19), lung ultrasound has been used to diagnose and monitor respiratory condition. The aim of the study was to describe lung ultrasound findings in children with a COVID-19 infection. Patients younger than 18 years old and positive for COVID-19, admitted to pediatric tertiary referral hospital were included. They were divided into two groups depending on the presence of respiratory symptoms. Lung ultrasound results were categorized into four degrees according to Soldati et al. score (J Ultrasound Med 39:1-7, 2020) and it was also described the presence and type of consolidation. Sixteen patients were recruited. The median age was 11 years old (IQR 2.8-12). Four children (25%) required admission to the intensive care unit. Six patients (37.5%) presented with respiratory symptoms. Most of them showed S.score of 2 and subpleural consolidations were observed in four cases (66.6%). Ten patients (62.5%) presented with non-respiratory symptoms, lung ultrasound showed S.score from 0 to 2. Three (30%) were diagnosed of multisystem inflammatory syndrome and lung ultrasounds showed S.score of 2 with bilateral pleural effusion.Conclusions: Children with COVID-19 and respiratory symptoms mostly showed a S.score of 2 and 3 with subpleural consolidations, upon the lung ultrasound assessment. What is Known: • Lung ultrasound is a useful tool for monitoring patients with respiratory symptoms in both adults and children. Lung ultrasounds are altered in adult patients with COVID-19. What is New: • Lung ultrasound might improve COVID-19 assessment, it could be a useful tool to diagnose and monitor patients throughout the COVID-19 pandemic. Even COVID-19 patients with non-respiratory symptoms have lung alterations that are visible on lung ultrasound.
- Published
- 2021
12. Nutritional status and nutrition support in critically ill children in Spain: Results of a multicentric study
- Author
-
Solana MJ, Manrique G, Fernández R, Slocker M, García M, Redondo S, Yun C, Gil R, Balaguer-Gargallo M, Rodríguez E, González-Posada A, Santiago C, Martín CM, Miñambres M, Sánchez M, Goñi C, López J, and López-Herce J
- Subjects
Nutrition support ,Caloric supply ,Protein supply ,Malnutrition ,Critically ill children ,Early enteral nutrition - Abstract
OBJECTIVES: Critically ill children are often malnourished and require nutrition support (NS). Early enteral nutrition (EEN) seems to be safe in critically ill patients. However, there is a scarcity of data about the management of EEN in sick pediatric patients. The aim of this study was to analyze the nutritional status, NS characteristics, macronutrient supply, and associations between NS and outcomes in critically ill children in Spain. METHODS: This was a multicentric, prospective, cross-sectional study involving critically ill children who received NS and with an expected length of stay (LOS) in the pediatric intensive care unit of =3 d. Anthropometric variables, characteristics of NS, EEN, nutrient supply, and complications were recorded. RESULTS: We enrolled 86 children. Undernutrition and overweight were more prevalent in children =2 y of age than in older children (undernutrition: 40 versus 19%, respectively; overweight: 22.2 versus 14.3%, respectively). Being overweight was associated with a shorter PICU LOS (5.8 ± 2 versus 9.8 ± 6.5; P = 0.005). EN was the preferred method for nutrient delivery. EEN was administered to 58.1% of patients and was more common in children >2 y of age than in younger patients (73.1 versus 44.4%; P = 0.015). EEN was safe and was associated with a higher caloric intake (81.6 ± 35.3 versus 59.6 ± 36.6; P = 0.019). There was a negative correlation between mean time to EN initiation and maximum energy supply (r = -0.32; P = 0.07). CONCLUSIONS: Malnutrition was prevalent among critically ill children in Spain. Being overweight was associated with a shorter PICU LOS. EEN was safe and was associated with a higher caloric intake; however, it is rarely used in PICUs in Spain.
- Published
- 2021
13. Device-associated multidrug-resistant bacteria surveillance in critically ill children: 10 years of experience
- Author
-
Girona M, Elena Fresán Ruiz, Garcia-Garcia A, Bobillo-Perez S, Balaguer-Gargallo M, Felipe-Villalobos A, Esteban ME, and Jordán-García I
- Subjects
antimicrobial resistance ,multidrug-resistant bacteria ,paediatrics ,paediatric intensive care ,nosocomial infection - Abstract
AIM: Multidrug-resistant bacterial infections are a public health problem worldwide. However, most of the information available refers to adults. The main objectives were to determine the incidence, risk factors, and outcomes for device-associated infections, especially those involving multidrug-resistant bacteria. METHODS: This is a prospective, observational study. Children aged =1 month and
- Published
- 2021
14. The different manifestations of COVID-19 in adults and children: a cohort study in an intensive care unit
- Author
-
Girona M, Bobillo-Perez S, Solé-Ribalta A, Hernandez-Platero L, Guitart C, Suarez R, Balaguer-Gargallo M, Cambra-Lasaosa FJ, Jordán-García I, KIDS-Corona study group, and Kids Corona Platform
- Subjects
Acute respiratory distress syndrome ,SARS-CoV-2 ,COVID-19 ,Multisystem inflammatory syndrome ,Biomarkers - Abstract
BACKGROUND: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has collapsed health systems worldwide. In adults, the virus causes severe acute respiratory distress syndrome (ARDS), while in children the disease seems to be milder, although a severe multisystem inflammatory syndrome (MIS-C) has been described. The aim was to describe and compare the characteristics of the severe COVID-19 disease in adults and children. METHODS: This prospective observational cohort study included the young adults and children infected with SARS-CoV-2 between March-June 2020 and admitted to the paediatric intensive care unit. The two populations were analysed and compared focusing on their clinical and analytical characteristics and outcomes. RESULTS: Twenty patients were included. There were 16 adults (80%) and 4 children (20%). No mortality was recorded. All the adults were admitted due to ARDS. The median age was 32 years (IQR 23.3-41.5) and the most relevant previous pathology was obesity (n = 7, 43.7%). Thirteen (81.3%) needed mechanical ventilation, with a median PEEP of 13 (IQR 10.5-14.5). Six (37.5%) needed inotropic support due to the sedation. Eight (50%) developed a healthcare-associated infection, the most frequent of which was central line-associated bloodstream infection (n = 7, 71.4%). One patient developed a partial pulmonary thromboembolism, despite him being treated with heparin. All the children were admitted due to MIS-C. Two (50%) required mechanical ventilation. All needed inotropic support, with a median vasoactive-inotropic score of 27.5 (IQR 17.5-30). The difference in the inotropic requirements between the two populations was statistically significant (37.5% vs. 100%, p < 0.001). The biomarker values were higher in children than in adults: mid-regional pro-adrenomedullin 1.72 vs. 0.78 nmol/L (p = 0.017), procalcitonin 5.7 vs. 0.19 ng/mL (p = 0.023), and C-reactive protein 328.2 vs. 146.9 mg/L (p = 0.005). N-terminal pro-B-type natriuretic peptide and troponins were higher in children than in adults (p = 0.034 and p = 0.039, respectively). CONCLUSIONS: Adults and children had different clinical manifestations. Adults developed severe ARDS requiring increased respiratory support, whereas children presented MIS-C with greater inotropic requirements. Biomarkers could be helpful in identifying susceptible patients, since they might change depending on the clinical features.
- Published
- 2021
15. Use of procalcitonin and C-reactive protein in the diagnosis of bacterial infection in infants with severe bronchiolitis
- Author
-
Alejandre-Galobardes C, Guitart C, Balaguer-Gargallo M, Torrús I, Bobillo-Perez S, Cambra-Lasaosa FJ, and Jordán-García I
- Subjects
parasitic diseases ,Bronchiolitis ,Bacterial infection ,Procalcitonin ,C-reactive protein - Abstract
The objective was to evaluate the use of procalcitonin (PCT) and C-reactive protein (CRP) for the diagnosis of bacterial infection in bronchiolitis patients. A prospective, single-centre, descriptive, and comparative observational study was carried out on patients with severe bronchiolitis admitted to the paediatric intensive care unit (PICU), from January 2011 to July 2017. Two cohorts were compared: patients with invasive bacterial infection (IBI) and patients with no bacterial infection (NBI). We included 675 patients, 399 of whom were males (59.1%), with median age of 47 days (IQR 25-100.3). Of them, 181 patients were diagnosed with IBI (26.8%). Seventy-two had sepsis (10.7%), 106 had pneumonia (15.7%), and 41 had a urinary tract infection (6.1%). PCT and CRP values were significantly higher in patients with IBI. ROC curves compared the ability of PCT and CRP to diagnose IBI at admission, 24 h, and 48 h. PCT showed a better AUC for diagnosing IBI, with statistically significant differences at all time points (p < 0.001). The best PCT cut-off for IBI diagnosis at admission was 1.4 ng/mL, with a sensitivity of 69% (95% CI 58.4-74.9) and a specificity of 91% (95% CI 88.1-92.5). Procalcitonin showed a better AUC for diagnosing both sepsis and pneumonia, which makes it an excellent predictor.Conclusion: We present PCT as a novel test in comparison with the traditional CRP screening test to discern which bronchiolitis patients have IBI. We highlight the importance of PCT for the diagnosis of pneumonia and sepsis, as it proved to be more sensitive and specific than CRP, with statistically significant differences. What is Known: • Bronchiolitis should be treated with antibiotics only when a bacterial infection is present. • The rate of antibiotic prescription in severe bronchiolitis is extremely high, so diagnostic tools are needed. What is New: • PCT is a good biomarker to discern which bronchiolitis patients have IBI, specially for pneumonia and sepsis diagnoses. It is more sensitive and specific than CRP, with statistically significant differences. • Implementation of PCT cut-off values may prevent unnecessary antibiotic use.
- Published
- 2021
16. Functional analysis of human glucokinase gene mutations causing MODY2: exploring the regulatory mechanisms of glucokinase activity
- Author
-
García-Herrero, C. M., Galán, M., Vincent, O., Flández, B., Gargallo, M., Delgado-Alvarez, E., Blázquez, E., and Navas, M. A.
- Published
- 2007
- Full Text
- View/download PDF
17. Procalcitonin-guided protocol decreased the antibiotic use in paediatric patients with severe bronchiolitis
- Author
-
Alejandre-Galobardes C, Balaguer-Gargallo M, Guitart C, Torrús I, Felipe-Villalobos A, Launes-Montana C, Cambra-Lasaosa FJ, and Jordán-García I
- Subjects
invasive bacterial infection ,antibiotics ,bronchiolitis ,stewardship ,procalcitonin - Abstract
AIM: Our aim was to determine the effectiveness and safety of a procalcitonin-guided protocol to decrease antibiotic use in infants with severe bronchiolitis. METHODS: This prospective, observational study was conducted at the Hospital Sant Joan de Déu from 2010 to 2017. Patients under the age of one were included if they were diagnosed with bronchiolitis, had a suspected bacterial infection and were admitted to the paediatric intensive care unit. A procalcitonin-guided protocol was established in 2014, and two cohorts were compared before and after implementation: 340 in 2010-2014 and 366 in 2015-2017. RESULTS: We recruited 706 patients (58.6% male) with a median age of 47 days and an interquartile range of 25.0-100.2. The rate for antibiotic use was 79.9%, and this differed before and after implementation (88.2% vs 72.1%, P = .003). Antibiotic stewardship and withdrawal decisions were higher after implementation (22.3% vs 36.4%, P = .005). The length of antibiotic treatment was also different between the two periods (8.65 ± 4.8 days vs 5.05 ± 3.18 days, P = .023). No adverse outcomes were observed due to the implementation of the protocol. CONCLUSION: The implementation of a procalcitonin-guided protocol seems to lead to a safe and general decrease in antibiotic use in paediatric patients with severe bronchiolitis.
- Published
- 2020
18. End-of-life care in a pediatric intensive care unit: the impact of the development of a palliative care unit
- Author
-
Bobillo-Perez S, Segura-Matute S, Girona M, Felipe-Villalobos A, Balaguer-Gargallo M, Hernandez-Platero L, Solé-Ribalta A, Guitart C, Jordán-García I, and Cambra-Lasaosa FJ
- Subjects
Withholding treatment ,Hospital mortality ,Withdrawal ,Pediatric intensive care units ,Palliative care - Abstract
BACKGROUND: The purpose of this paper is to describe how end-of-life care is managed when life-support limitation is decided in a Pediatric Intensive Care Unit and to analyze the influence of the further development of the Palliative Care Unit. METHODS: A 15-year retrospective study of children who died after life-support limitation was initiated in a pediatric intensive care unit. Patients were divided into two groups, pre- and post-palliative care unit development. Epidemiological and clinical data, the decision-making process, and the approach were analyzed. Data was obtained from patient medical records. RESULTS: One hundred seventy-five patients were included. The main reason for admission was respiratory failure (86/175). A previous pathology was present in 152 patients (61/152 were neurological issues). The medical team and family participated together in the decision-making in 145 cases (82.8%). The family made the request in 10 cases (9 vs. 1, p = 0.019). Withdrawal was the main life-support limitation (113/175), followed by withholding life-sustaining treatments (37/175). Withdrawal was more frequent in the post-palliative group (57.4% vs. 74.3%, p = 0.031). In absolute numbers, respiratory support was the main type of support withdrawn. CONCLUSIONS: The main cause of life-support limitation was the unfavourable evolution of the underlying pathology. Families were involved in the decision-making process in a high percentage of the cases. The development of the Palliative Care Unit changed life-support limitation in our unit, with differences detected in the type of patient and in the strategy used. Increased confidence among intensivists when providing end-of-life care, and the availability of a Palliative Care Unit may contribute to improvements in the quality of end-of-life care.
- Published
- 2020
19. Pro-atrial natriuretic peptide and pro-adrenomedullin before cardiac surgery in children. Can we predict the future?
- Author
-
Bobillo-Perez S, Girona M, Corniero-Alonso P, Solé-Ribalta A, Balaguer-Gargallo M, Esteban-Torne E, Valls-Lafon A, Jordán-García I, and Cambra-Lasaosa FJ
- Abstract
INTRODUCTION AND OBJECTIVE: Pro-atrial natriuretic peptide (proANP) and pro-adrenomedullin (proADM) levels increase in acute heart failure and sepsis. After cardiac surgery, children may require increased support in the intensive care unit and may develop complications. The aim of this study was to evaluate the utility of proANP and proADM values, determined prior to cardiac surgery, for predicting the need for increased respiratory or inotropic support during the post-operative period. METHODS: This was a prospective study in children. Biomarkers were analyzed before surgery using a single blood test. The primary endpoints were the need for greater respiratory and/or inotropic support during the post-operative period. Secondary endpoints were the relationship between these biomarkers and complications after surgery. RESULTS: One hundred thirteen patients were included. ProANP and proADM were higher in children who required greater respiratory and inotropic support, especially proANP; for increased respiratory support, 578.9 vs. 106.6 pmol/L (p = 0.004), and for increased inotropic support, 1938 vs. 110.4 pmol/L (p = 0.002). ProANP had a greater AUC than proADM for predicting increased respiratory support after surgery: 0.791 vs. 0.724. A possible cut-off point for proANP could be = 325 pmol/L (sensitivity = 66.7% and specificity = 88.8%). In the multivariate analysis, the logarithmic transformation of proANP was independently associated with the need for increased respiratory support (OR = 3.575). Patients who presented a poor outcome after cardiac surgery also had higher biomarker values (proADM, p = 0.013; proANP, p = 0.001). CONCLUSIONS: Elevated proANP before cardiac surgery may identify which children will need more respiratory and inotropic support during the post-operative period.
- Published
- 2020
20. Effects of local antimicrobials, as adjuncts to subgingival debridement, compared to subgingival debridement alone, in chronic periodontitis patients, in terms of pocket probing depth changes: a systematic review: RC 009
- Author
-
García-Gargallo, M., Matesanz, P., Figuero, E., Bascones-Martínez, A., Sanz, M., and Herrera, D.
- Published
- 2012
21. EVIDENCE-BASED NUTRITIONAL RECOMMENDATIONS FOR THE PREVENTION AND TREATMENT OF OVERWEIGHT AND OBESITY IN ADULTS. THE FESNAD-SEEDO CONSENSUS.: 747 accepted poster
- Author
-
Formiguera, X., Basulto, J., Breton, I., Gargallo, M., Quiles, J., and Salas-Salvadó, J.
- Published
- 2012
22. Counter-current flow limitations during hot leg injection in pressurized water reactors
- Author
-
Gargallo, M., Schulenberg, T., Meyer, L., and Laurien, E.
- Published
- 2005
- Full Text
- View/download PDF
23. Procalcitonin to stop antibiotics after cardiovascular surgery in a pediatric intensive care unit-The PROSACAB study
- Author
-
Bobillo-Perez S, Solé-Ribalta A, Balaguer-Gargallo M, Esteban-Torne E, Girona M, Hernandez-Platero L, Segura-Matute S, Felipe-Villalobos A, Cambra-Lasaosa FJ, Launes-Montana C, and Jordán-García I
- Abstract
INTRODUCTION AND OBJECTIVE: Children admitted to the pediatric intensive care unit after cardiovascular surgery usually require treatment with antibiotics due to suspicion of infection. The aim of this study was to assess the effectiveness of procalcitonin in decreasing the duration of antibiotic treatment in children after cardiovascular surgery. METHODS: Prospective, interventional study carried out in a pediatric intensive care unit. Included patients under 18 years old admitted after cardiopulmonary bypass. Two groups were compared, depending on the implementation of the PCT-guided protocol to stop or de-escalate the antibiotic treatment (Group 1, 2011-2013 and group 2, 2014-2018). This new protocol was based on the decrease of the PCT value by 20% or 50% with respect to the maximum value of PCT. Primary endpoints were mortality, stewardship indication, duration of antibiotic treatment, and antibiotic-free days. RESULTS: 886 patients were recruited. There were 226 suspicions of infection (25.5%), and they were confirmed in 38 cases (16.8%). The global rate of infections was 4.3%. 102 patients received broad-spectrum antibiotic (4.7±1.7 days in group 1, 3.9±1 days in group 2 with p = 0.160). The rate of de-escalation was higher in group 2 (30/62, 48.4%) than in group 1 (24/92, 26.1%) with p = 0.004. A reduction of 1.1 days of antibiotic treatment (group 1, 7.7±2.2 and group 2, 6.7±2.2, with p = 0.005) and 2 more antibiotic free-days free in PICU in group 2 were observed (p = 0.001), without adverse outcomes. CONCLUSIONS: Procalcitonin-guided protocol for stewardship after cardiac surgery seems to be safe and useful to decrease the antibiotic exposure. This protocol could help to reduce the duration of broad-spectrum antibiotics and the duration of antibiotics in total, without developing complications or adverse effects.
- Published
- 2019
24. Prognostic value of biomarkers after cardiopulmonary bypass in pediatrics: The prospective PANCAP study
- Author
-
Bobillo-Perez S, Jordán-García I, Corniero-Alonso P, Balaguer-Gargallo M, Solé-Ribalta A, Esteban ME, Esteban-Torne E, and Cambra-Lasaosa FJ
- Subjects
hormones, hormone substitutes, and hormone antagonists - Abstract
OBJECTIVE: To assess the usefulness of procalcitonin, pro-adrenomedullin and pro-atrial natriuretic peptide as predictors of need for mechanical ventilation and postoperative complications (need for inotropic support and bacterial infection) in critically ill pediatric patients after cardiopulmonary bypass. DESIGN: A prospective, observational study. SETTING: Pediatric intensive care unit. PATIENTS: Patients under 18 years old admitted after cardiopulmonary bypass. MEASURAMENTS AND MAIN RESULTS: Serum levels of procalcitonin, pro-adrenomedullin and pro-atrial natriuretic peptide were determined immediately after bypass and at 24-36 hours. Their values were correlated with the need for mechanical ventilation, inotropic support and bacterial infection. One hundred eleven patients were recruited. Septal defects (30.6%) and cardiac valve disease (17.1%) were the most frequent pathologies. 40.7% required mechanical ventilation, 94.6% inotropic support and 15.3% presented invasive bacterial infections. Pro-adrenomedullin and pro-atrial natriuretic peptide showed significant high values in patients needing mechanical ventilation. Cut-off values higher than 1.22 nmol/L and 215.3 pmol/L, respectively for each biomarker, may indicate need for mechanical ventilation with an AUC of 0.721 and 0.746 at admission and 0.738 and 0.753 at 24-36 hours, respectively but without statistical differences. Pro-adrenomedullin and procalcitonin showed statistically significant high values in patients with bacterial infections. CONCLUSIONS: After bypass, pro-adrenomedullin and pro-atrial natriuretic peptide are suitable biomarkers to predict the need for mechanical ventilation. Physicians should be alert if the values of these markers are high so as not to progress to early extubation. Procalcitonin is useful for predicting bacterial infection. This is a preliminary study and more clinical studies should be done to confirm the value of pro-adrenomedullin and pro-atrial natriuretic peptide as biomarkers after cardiopulmonary bypass.
- Published
- 2019
25. Lung Ultrasound to Assess the Etiology of Persistent Pulmonary Hypertension of the Newborn (LUPPHYN Study): A Pilot Study
- Author
-
Del Rey Hurtado de Mendoza B, Sanchez-de-Toledo J, Bobillo-Perez S, Girona M, Balaguer-Gargallo M, and Rodríguez-Fanjul J
- Subjects
Persistent pulmonary hypertension ,Extracorporeal membrane oxygenation therapy ,Lung ultrasound - Abstract
INTRODUCTION: Persistent pulmonary hypertension of the newborn (PPHN) is a neonatal syndrome associated with significant morbidity and mortality that is caused by the failure of postnatal drop in pulmonary vascular resistance. In extreme cases, patients may require extracorporeal membrane oxygenation therapy (ECMO). The aim of this study was to explore lung ultrasound (LUS) patterns in newborns with PPHN requiring ECMO. PATIENTS AND METHODS: From January 2014 to January 2018, LUS was performed on patients with PPHN admitted for ECMO treatment. PPHN diagnosis was based on clinical and echocardiographic findings. LUS was performed before patients underwent ECMO cannulation. An underlying diagnosis was made taking into account the patient's complete medical history, excluding LUS information. A blinded physician, unaware of the patient's clinical condition, analyzed the stored ultrasound images. Results were then compared with chest x-ray (CXR) diagnoses. RESULTS: Seventeen patients were recruited; 12 were male (70.6%). The median gestational age was 38.7 weeks, with 13 term newborns (76.5%). Twelve were cannulated for VA ECMO, with a median ECMO run of 111.2 h. Six patients (35%) survived. Patients with alveolar capillary dysplasia with misaligned pulmonary veins, fetal ductus arteriosus constriction, or sepsis had normal LUS patterns (A-lines with lung sliding). LUS showed a better sensitivity (88.9%) and specificity (85%) than CXR (55.6 and 77.5%, respectively) in identifying patients with nonparenchymal lung disease. CONCLUSIONS: LUS can provide essential information to help diagnose the underlying cause of PPHN in an earlier and more effective way than CXR. LUS is suitable for routine utilization in the intensive care unit.
- Published
- 2019
26. Venoarterial extracorporeal membrane oxygenation support for neonatal and pediatric refractory septic shock: more than 15 years of learning
- Author
-
Solé-Ribalta A, Jordán-García I, Bobillo-Perez S, Moreno-Hernando J, Balaguer-Gargallo M, Hernandez-Platero L, Segura-Matute S, Cambra-Lasaosa FJ, Esteban-Torne E, and Rodríguez-Fanjul J
- Subjects
Pediatric ,surgical procedures, operative ,Extracorporeal membrane oxygenation ,Neonatal ,Sepsis ,Septic shock ,Mortality factors - Abstract
The objective of the study was to report our institutional experience in the management of children and newborns with refractory septic shock who required venoarterial extracorporeal membrane oxygenation (VA ECMO) treatment, and to identify patient-and infection-related factors associated with mortality. This is a retrospective case series in an intensive care unit of a tertiary pediatric center. Inclusion criteria were patients = 18 years old who underwent a VA ECMO due to a refractory septic shock due to circulatory collapse. Patient conditions and support immediately before ECMO, analytical and hemodynamic parameter evolution during ECMO, and post-canulation outcome data were collected. Twenty-one patients were included, 13 of them (65%) male. Nine were pediatric and 12 were newborns. Median septic shock duration prior to ECMO was 29.5 h (IQR, 20-46). Eleven patients (52.4%) suffered cardiac arrest (CA). Neonatal patients had worse Sepsis Organ Failure Assessment (SOFA) score, Oxygenation Index and PaO(2)/FiO(2) ratio, blood gas analysis, lactate levels, and left ventricular ejection fraction compared to pediatric patients. Survival was 33.3% among pediatric patients (60% if we exclude pneumococcal cases) and 50% among newborns. Hours of sepsis evolution and mean airway pressure (MAP) prior to ECMO were significantly higher in the non-survivor group. CA was not a predictor of mortality. Streptococcus pneumoniae infection was a mortality risk factor. There was an improvement in survival during the second period, from 14.3 to 57.2%, related to shorter sepsis evolution before ECMO placement, better candidate selection, and greater ECMO support once the patient was placed. CONCLUSION: Patients with refractory septic shock should be transferred precociously to a referral ECMO center. However, therapy should be used with caution in patients with vasoplegic pattern shock or S. pneumoniae sepsis. What is Known: • Children with refractory septic shock have significant mortality rates, and although ECMO is recommended, overall survival is low. • There are no studies regarding characteristics of infections as predictors of pediatric survival in ECMO. What is New: • Septic children should be transferred precociously to referral ECMO centers during the first hours if patients do not respond to conventional therapy. • Treatment should be used with caution in patients with vasoplegic pattern shock or S. pneumoniae sepsis.
- Published
- 2018
27. Ultrasound-guided or landmark techniques for central venous catheter placement in critically ill children
- Author
-
Oulego-Erroz I, González-Cortes R, García-Soler P, Balaguer-Gargallo M, Frías-Pérez M, Mayordomo-Colunga J, Llorente-de-la-Fuente A, Santos-Herraiz P, Menéndez-Suso JJ, Sánchez-Porras M, Palanca-Arias D, Clavero-Rubio C, Holanda-Peña MS, Renter-Valdovinos L, Fernández-De-Miguel S, and Rodríguez-Núñez A
- Subjects
Paediatric intensive care unit ,Central venous catheterization ,Children ,Landmark ,Ultrasound - Abstract
PURPOSE: To assess whether ultrasound guidance improves central venous catheter placement outcomes compared to the landmark technique in critically ill children. METHODS: A prospective multicentre observational study was carried out in 26 paediatric intensive care units over 6 months. Children 0-18 years old who received a temporary central venous catheter, inserted using either ultrasound or landmark techniques, were eligible. The primary outcome was the first-attempt success rate. Secondary outcomes included overall placement success, number of puncture attempts, number of procedures requiring multiple punctures (> 3 punctures), number of procedures requiring punctures at more than one vein site and immediate mechanical complications. To account for potential confounding factors, we used propensity scores. Our primary analysis was based on 1:1 propensity score matching. The association between cannulation technique and outcomes in the matched cohort was estimated using generalized estimating equations and mixed-effects models to account for patient-level and hospital-level confounders. RESULTS: Five hundred central venous catheter-placement procedures involving 354 patients were included. Ultrasound was used for 323 procedures, and the landmark technique was used for 177. Two hundred and sixty-six procedures were matched (133 in the ultrasound group and 133 in the landmark group). Ultrasound was associated with an increase in the first-attempt success rate [46.6 vs. 30%, odds ratio 2.09 (1.26-3.46); p
- Published
- 2018
28. Kinetics of Procalcitonin in Pediatric Patients on Extracorporeal Membrane Oxygenation
- Author
-
Bobillo-Perez S, Rodríguez-Fanjul J, Solé-Ribalta A, Moreno-Hernando J, Balaguer-Gargallo M, Esteban-Torne E, Cambra-Lasaosa FJ, and Jordán-García I
- Subjects
surgical procedures, operative ,parasitic diseases ,outcome ,ECMO ,bacterial infections and mycoses ,multiple organ dysfunction syndrome ,hormones, hormone substitutes, and hormone antagonists ,infection ,procalcitonin ,C-reactive protein - Abstract
OBJECTIVES: To assess the kinetics of procalcitonin (PCT) and C-reactive protein (CRP) in pediatric patients who required extracorporeal membrane oxygenation (ECMO) and to analyze its relationship with morbidity and mortality. PATIENTS AND METHODS: Prospective observational study including pediatric patients who required ECMO. Both PCT and CRP were sequentially drawn before ECMO (P0) and until 72 hours after ECMO. RESULTS: A total of 40 patients were recruited. Two cohorts were established based on the value of the P0 PCT (>10 ng/mL). Comparing the kinetics of PCT and CRP in these cohorts, the described curves were the expected for each clinical situation. The cutoff for P0 PCT to predict multiple organ dysfunction syndrome was 2.55 ng/mL (sensibility 83%, specificity 100%). Both PCT and CRP did not predict risk of neurologic sequelae or mortality in any group. CONCLUSIONS: Procalcitonin does not seem to be modified by ECMO and could be a good biomarker of evolution.
- Published
- 2018
29. Bronchiolitis Score of Sant Joan de Déu: BROSJOD Score, validation and usefulness
- Author
-
Balaguer-Gargallo M, Alejandre-Galobardes C, Vila-Perez D, Esteban-Torne E, Carrasco JL, Cambra-Lasaosa FJ, and Jordán-García I
- Subjects
score ,bronchiolitis - Abstract
OBJECTIVE: To validate the bronchiolitis score of Sant Joan de Déu (BROSJOD) and to examine the previously defined scoring cutoff. PATIENTS AND METHODS: Prospective, observational study. BROSJOD scoring was done by two independent physicians (at admission, 24 and 48 hr). Internal consistency of the score was assessed using Cronbach's a. To determine inter-rater reliability, the concordance correlation coefficient estimated as an intraclass correlation coefficient (CCC) and limits of agreement estimated as the 90% total deviation index (TDI) were estimated. An expert opinion was used to classify patients according to clinical severity. A validity analysis was conducted comparing the 3-level classification score to that expert opinion. Volume under the surface (VUS), predictive values, and probability of correct classification (PCC) were measured to assess discriminant validity. RESULTS: About 112 patients were recruited, 62 of them (55.4%) males. Median age: 52.5 days (IQR: 32.75-115.25). The admission Cronbach's a was 0.77 (CI95%: 0.71; 0.82) and at 24 hr it was 0.65 (CI95%: 0.48; 0.7). The inter-rater reliability analysis was: CCC at admission 0.96 (95%CI 0.94-0.97), at 24 h 0.77 (95%CI 0.65-0.86), and at 48 hr 0.94 (95%CI 0.94-0.97); TDI 90%: 1.6, 2.9, and 1.57, respectively. The discriminant validity at admission: VUS of 0.8 (95%CI 0.70-0.90), at 24 h 0.92 (95%CI 0.85-0.99), and at 48 hr 0.93 (95%CI 0.87-0.99). The predictive values and PCC values were within 38-100% depending on the level of clinical severity. CONCLUSION: There is a high inter-rater reliability, showing the BROSJOD score to be reliable and valid, even when different observers apply it. Pediatr Pulmonol. 2017;52:533-539. © 2016 Wiley Periodicals, Inc.
- Published
- 2017
30. Técnicas de preservación de alveolo y de aumento del reborde alveolar: revisión de la literatura
- Author
-
García Gargallo, M., Yassin García, S., and Bascones Martínez, A.
- Subjects
Preservación de alveolo ,alveolar ridge deformities ,alveolar crest preservation ,rebordes alveolares deformados ,Ridge preservation ,técnicas de aumento de tejidos duros y/o blandos ,alveolar ridge augmentation - Abstract
La pérdida dentaria produce una serie de cambios dimensionales que afectan tanto a los tejidos duros como a los tejidos blandos ocasionando frecuentemente defectos en el reborde alveolar. La prevención y el tratamiento de dichos defectos, tiene como objetivo la preservación o el aumento de los tejidos duros y/o blandos para mejorar las condiciones del reborde para una futura restauración protésica. Existen diversas técnicas quirúrgicas encaminadas a prevenir o minimizar los cambios dimensionales en alveolos postextracción (técnicas de preservación de alveolo) y otras destinadas a la reconstrucción de dichas alteraciones anatómicas. En general, en defectos pequeños o moderados una técnica de aumento de tejidos blandos puede ser suficiente. Sin embargo, en defectos más severos o en aquellas localizaciones en las que se planifique la posterior colocación de implantes, un enfoque combinado (aumento de tejido duros y blandos) y/o en distintas fases puede ser necesario. En este artículo se revisan los cambios dimensionales tras la extracción o pérdida dental, los tipos de la deformidad del reborde así como las diferentes técnicas de preservación de alveolo y de aumento de la cresta alveolar. The extraction of single as well as multiple teeth induces a series of adaptative changes in the soft and hard tissues that results in an overall regress of the edentulous site(s). The prevention and treatment of alveolar ridge deformities aims preserving and reconstructing soft and hard tissues of the edentulous ridge in order to render better conditions at the site for the future prosthesis installation. Different surgical techniques have been proposed to prevent ridge collapse after tooth extraction or to reconstruct the lost anatomy prior to prosthesis installation. In general terms, in mild defects, soft tissue augmentation may be sufficient to repair the deformity. However, in more severe deformities a combined or staged approach may be more appropriate. This article reviews the dimensional changes after tooth extraction, types alveolar ridge deformities and various techniques for the prevention and treatment of alveolar ridge defects.
- Published
- 2016
31. Time of parenteral nutrition in paediatric critical care patients, prior nutritional status probably makes the difference?
- Author
-
Balaguer-Gargallo M and Jordán-García I
- Published
- 2016
32. Técnicas de preservación de alveolo y de aumento del reborde alveolar: revisión de la literatura
- Author
-
García Gargallo,M., Yassin García,S., and Bascones Martínez,A.
- Subjects
Preservación de alveolo ,rebordes alveolares deformados ,técnicas de aumento de tejidos duros y/o blandos - Abstract
La pérdida dentaria produce una serie de cambios dimensionales que afectan tanto a los tejidos duros como a los tejidos blandos ocasionando frecuentemente defectos en el reborde alveolar. La prevención y el tratamiento de dichos defectos, tiene como objetivo la preservación o el aumento de los tejidos duros y/o blandos para mejorar las condiciones del reborde para una futura restauración protésica. Existen diversas técnicas quirúrgicas encaminadas a prevenir o minimizar los cambios dimensionales en alveolos postextracción (técnicas de preservación de alveolo) y otras destinadas a la reconstrucción de dichas alteraciones anatómicas. En general, en defectos pequeños o moderados una técnica de aumento de tejidos blandos puede ser suficiente. Sin embargo, en defectos más severos o en aquellas localizaciones en las que se planifique la posterior colocación de implantes, un enfoque combinado (aumento de tejido duros y blandos) y/o en distintas fases puede ser necesario. En este artículo se revisan los cambios dimensionales tras la extracción o pérdida dental, los tipos de la deformidad del reborde así como las diferentes técnicas de preservación de alveolo y de aumento de la cresta alveolar.
- Published
- 2016
33. Glutamine effects on heat shock protein 70 and interleukines 6 and 10: Randomized trial of glutamine supplementation versus standard parenteral nutrition in critically ill children
- Author
-
Jordán-García I, Balaguer-Gargallo M, Esteban ME, Cambra-Lasaosa FJ, Felipe-Villalobos A, Hernandez-Platero L, Alsina L, Molero M, Villaronga M, and Esteban-Torne E
- Published
- 2016
34. Procalcitonin-guidance reduces antibiotic exposure in children with nosocomial infection (PRORANI)
- Author
-
Launes-Montana C, Esteban-Torne E, Balaguer-Gargallo M, Alsina M, Cambra-Lasaosa FJ, and Jordán-García I
- Published
- 2016
35. Clinical efficacy of desensitizing mouthwashes for the control of dentin hypersensitivity and root sensitivity: a systematic review and meta‐analysis
- Author
-
Molina, A, primary, García‐Gargallo, M, additional, Montero, E, additional, Tobías, A, additional, Sanz, M, additional, and Martín, C, additional
- Published
- 2016
- Full Text
- View/download PDF
36. Evaluation of new chlorhexidine- and cetylpyridinium chloride-based mouthrinse formulations adjunctive to scaling and root planing: pilot study
- Author
-
García-Gargallo, M, primary, Zurlohe, M, additional, Montero, E, additional, Alonso, B, additional, Serrano, J, additional, Sanz, M, additional, and Herrera, D, additional
- Published
- 2016
- Full Text
- View/download PDF
37. Importancia del agua en la hidratación de la población española: documento FESNAD 2010
- Author
-
Iglesias Rosado, C., Villarino Marín, A. L., Martínez, J. A., Cabrerizo, L., Gargallo, M., Lorenzo, H., Quiles, J., Planas, M., Polanco, I., Romero de Ávila, D., Russolillo, J., Farré, R., Moreno Villares, J. M., Riobó, P., and Salas-Salvadó, J.
- Subjects
Anciano ,Population ,Water ,Hydration ,Agua ,Hidratación ,Sed ,Elderly ,Niño ,Bebida carbonatada ,Población ,Child ,Thirst ,Carbonated beverages - Abstract
Para cualquier persona sana, la sed es una guía adecuada para tomar agua, excepto para los bebés, los deportistas y la mayoría de las personas enfermas y ancianas. En estos casos conviene programar momentos para ingerir agua, ya que la gran demanda y los mecanismos fisiológicos que determinan la sed en estas situaciones pueden condicionar desequilibrios en el balance hídrico con importantes consecuencias para la salud o el rendimiento físico o intelectual. Nuestro organismo posee una serie de mecanismos que le permiten mantener constante el contenido de agua, mediante un ajuste entre los ingresos y las pérdidas. El balance hídrico viene determinado por la ingestión (agua de bebida, líquidos, agua contenida en los alimentos) y la eliminación (orina, heces, a través de la piel y de aire espirado por los pulmones). El fallo de estos mecanismos y las consiguientes alteraciones del balance acuoso, pueden producir graves trastornos capaces de poner en peligro la vida del individuo. En el presente documento se analizan las evidencias en cuanto a los factores que condicionan las necesidades hídricas en las diferentes etapas de la vida y situaciones fisiológicas, así como las consecuencias de un desequilibrio en el balance hídrico en diferentes situaciones. Una correcta hidratación la podemos conseguir mediante nuestra alimentación y el uso de agua u otras bebidas. Aunque el agua es la bebida por excelencia y representa la forma ideal de reponer nuestras pérdidas e hidratarnos, debemos de ser conscientes de que, desde el principio de los tiempos, hemos buscado otras fuentes de líquidos con capacidad de hidratación. En las últimas décadas ha aumentado el consumo de diferentes bebidas, proliferando las bebidas con azúcar. Dado que el consumo excesivo de azúcar se ha relacionado con la obesidad y otras enfermedades crónicas, es evidente que debe racionalizarse el uso de estas bebidas calóricas especialmente en niños. En este documento se presentan todas estas consideraciones en cuanto a la hidratación, y se realizan diferentes recomendaciones al respecto. For any healthy individual, thirst is an appropriate sign to drink water, except for babies, sportsmen, and most of ill and elderly people. In these instances, it is convenient to schedule appropriate times to drink water since great demands and the physiological mechanisms that determine thirst in these situations may condition water unbalances with important consequences for health and the physical and intellectual performance. The human body has a number of mechanisms that allow keeping constant the water content by adjusting intakes and wastes. Water balance is determined by intake (consumed water, beverages, and water contained in foods) and wastes (urine, stools, the skin, and expired air from the lungs). Failure of these mechanisms and subsequent impairments in water balance may produce severe disarrangements that may threaten somebody´s life. In the present document, we analyze the evidences regarding the factors conditioning water needs in the different life stages and physiological situations, as well as the consequences of water unbalance under different situations. A proper hydration may be achieved by feeding and the use of water and other liquids. Although water is the beverage by excellence and represents the ideal way of restoring the losses and get hydrated, we should be aware that, from the very beginning, we have sought other liquid sources with hydration properties. In the last decades we have increased the consumption of different beverages, with a proliferation of sugar-containing beverages. Since excessive sugar consumption has been related to obesity and other chronic conditions, it is evident that the use of these caloric beverages should be rationalized, especially in children. In this document all the considerations regarding hydration are presented and different recommendations are exposed.
- Published
- 2011
38. Importancia del agua en la hidratación de la población española: documento FESNAD 2010
- Author
-
Iglesias-Rosado, C. (C.), Villarino-Marin, A.L. (A.L.), Martinez, J.A. (José Alfredo), Cabrerizo, L. (L.), Gargallo, M. (M.), Lorenzo, H. (H.), Quiles, J. (Joan), Planas, M. (M.), Polanco, I. (I.), Romero-de-Avila, D. (D.), Rusolillo, J. (J.), Farre, R. (R.), Moreno-Villares, J.M. (José Manuel), Riobo, P. (P.), and Salas-Salvado, J. (Jordi)
- Subjects
Anciano ,Population ,Water ,Hydration ,Agua ,Hidratación ,Sed ,Elderly ,Niño ,Bebida carbonatada ,Población ,Child ,Thirst ,Carbonated beverages - Abstract
Para cualquier persona sana, la sed es una guía adecuada para tomar agua, excepto para los bebés, los deportistas y la mayoría de las personas enfermas y ancianas. En estos casos conviene programar momentos para ingerir agua, ya que la gran demanda y los mecanismos fisiológicos que determinan la sed en estas situaciones pueden condicionar desequilibrios en el balance hídrico con importantes consecuencias para la salud o el rendimiento físico o intelectual. Nuestro organismo posee una serie de mecanismos que le permiten mantener constante el contenido de agua, mediante un ajuste entre los ingresos y las pérdidas. El balance hídrico viene determinado por la ingestión (agua de bebida, líquidos, agua contenida en los alimentos) y la eliminación (orina, heces, a través de la piel y de aire espirado por los pulmones). El fallo de estos mecanismos y las consiguientes alteraciones del balance acuoso, pueden producir graves trastornos capaces de poner en peligro la vida del individuo. En el presente documento se analizan las evidencias en cuanto a los factores que condicionan las necesidades hídricas en las diferentes etapas de la vida y situaciones fisiológicas, así como las consecuencias de un desequilibrio en el balance hídrico en diferentes situaciones. Una correcta hidratación la podemos conseguir mediante nuestra alimentación y el uso de agua u otras bebidas. Aunque el agua es la bebida por excelencia y representa la forma ideal de reponer nuestras pérdidas e hidratarnos, debemos de ser conscientes de que, desde el principio de los tiempos, hemos buscado otras fuentes de líquidos con capacidad de hidratación. En las últimas décadas ha aumentado el consumo de diferentes bebidas, proliferando las bebidas con azúcar. Dado que el consumo excesivo de azúcar se ha relacionado con la obesidad y otras enfermedades crónicas, es evidente que debe racionalizarse el uso de estas bebidas calóricas especialmente en niños. En este documento se presentan todas estas consideraciones en cuanto a la hidratación, y se realizan diferentes recomendaciones al respecto.
- Published
- 2011
39. Low pressure corium dispersion experiments in the DISCO test facility with cold simulant fluids
- Author
-
Meyer, L., Gargallo, M., Kirstahler, M., Schwall, M., Wachter, E., and Wörner, G.
- Subjects
ddc:620 ,Engineering & allied operations - Published
- 2006
- Full Text
- View/download PDF
40. Clinical efficacy of desensitizing mouthwashes for the control of dentin hypersensitivity and root sensitivity: a systematic review and meta-analysis.
- Author
-
Molina, A, García‐Gargallo, M, Montero, E, Tobías, A, Sanz, M, and Martín, C
- Subjects
TOOTH sensitivity ,CONFIDENCE intervals ,INFORMATION storage & retrieval systems ,MEDICAL databases ,MEDLINE ,META-analysis ,MOUTHWASHES ,ONLINE information services ,PLACEBOS ,PROBABILITY theory ,REGRESSION analysis ,HEALTH self-care ,SELF-evaluation ,TOOTH roots ,SYSTEMATIC reviews ,EVIDENCE-based dentistry ,RANDOMIZED controlled trials ,RESEARCH bias ,BLIND experiment ,DESCRIPTIVE statistics ,PREVENTION - Abstract
Objective This systematic review aimed to evaluate the scientific evidence on the efficacy of desensitizing mouthwashes for the treatment of dentin hypersensitivity ( DH) and root sensitivity ( RS). Material and methods A thorough search in MEDLINE, PubMed and Cochrane Plus Library was conducted up to February 2015. Randomized clinical trials, parallel, double-blinded and placebo-controlled, with a follow-up of at least 6 weeks, reporting changes on response to tactile stimuli, thermal/evaporative stimuli or patients' subjective assessment of the pain experienced during their daily life after the home use of desensitizing mouthwashes were considered for inclusion. Results The screening of titles and abstracts resulted in seven publications meeting the eligibility criteria. The desensitizing agents evaluated were potassium nitrate ( n = 5), aluminium lactate ( n = 1) and sodium fluoride ( n = 1). A meta-analysis for each of the hypersensitivity stimuli was performed. Results demonstrated statistically significant reduction in sensitivity scores favouring test group when DH was assessed by means of patients' self-reported pain experience ( SMD at 8 weeks = 0.77; 95% CI [0.23; 1.31]; P = 0.005). No significant effects were detected in response to tactile or thermal/evaporative stimuli. Meta-regression analysis demonstrated a tendency towards an increased effect favouring test group for the patients' subjective perception, whereas tactile and thermal/evaporative stimuli showed a slight tendency towards a reduction in the efficacy of the test mouthwash. Conclusions There exists a tendency towards a decrease in DH or RS scores with time in both treatment groups, with significant differences in favour of test group when sensitivity is evaluated in terms of patients' self-reported sensitivity symptoms. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
41. New coordination compounds of palladium(II) with iminodiacetic acid
- Author
-
González-Vílchez, F., Castillo-Martos, M., and Gargallo, M. F.
- Published
- 1977
- Full Text
- View/download PDF
42. Fisioteràpia postquirúrgica en el tractament de l'osteosarcoma: salvament d'extremitats i amputació
- Author
-
Gargallo, M. Lluïsa and Serra Gabriel, M. Rosa
- Published
- 2001
43. Epidemiología y hallazgos clínicos de la sepsis neonatal tardía en la unidad de cuidados intensivos pediátricos
- Author
-
Pociello Almiñana, N., primary, Balaguer Gargallo, M., additional, Jordán García, I., additional, Corrales Magin, E., additional, Esteban Torne, E., additional, Muñoz Almagro, C., additional, and Palomeque Rico, A., additional
- Published
- 2007
- Full Text
- View/download PDF
44. Trastornos hidroelectrolíticos en postoperados de tumores cerebrales
- Author
-
Segura Matute, S., primary, Balaguer Gargallo, M., additional, Cambra Lasaosa, F.J., additional, Zambudio Sert, S., additional, Martín Rodrigo, J.M., additional, and Palomeque Rico, A., additional
- Published
- 2007
- Full Text
- View/download PDF
45. Taquicardia paroxística supraventricular en el niño y el lactante
- Author
-
Balaguer Gargallo, M., primary, Jordán García, I., additional, Caritg Bosch, J., additional, Cambra Lasaosa, F.J., additional, Prada Hermogenes, F., additional, and Palomaque Rico, A., additional
- Published
- 2007
- Full Text
- View/download PDF
46. O.58. Experiencia en ventilación domiciliaria en pacientes pediátricos: Traqueostomía y ventilación no invasiva
- Author
-
Lasuen del Olmo, N., primary, Pons Ódena, M., additional, Ricart Campos, S., additional, Balaguer Gargallo, M., additional, Cambra Lasaosa, F.J., additional, and Palomeque Rico, A., additional
- Published
- 2007
- Full Text
- View/download PDF
47. Functional analysis of human glucokinase gene mutations causing MODY2: exploring the regulatory mechanisms of glucokinase activity
- Author
-
García-Herrero, C. M., primary, Galán, M., additional, Vincent, O., additional, Flández, B., additional, Gargallo, M., additional, Delgado-Alvarez, E., additional, Blázquez, E., additional, and Navas, M. A., additional
- Published
- 2006
- Full Text
- View/download PDF
48. Familial transmission of a duplication‐deficiency X chromosome associated with partial Turner syndrome
- Author
-
Aller, V., primary, Gargallo, M., additional, and Abrisqueta, J. A., additional
- Published
- 1995
- Full Text
- View/download PDF
49. Drugs in the treatment of obesity: sibutramine, orlistat and rimonabant.
- Author
-
Rubio MA, Gargallo M, Millán AI, Moreno B, Rubio, Miguel A, Gargallo, Manuel, Isabel Millán, Ana, and Moreno, Basilio
- Abstract
Background: Modification of lifestyle is the main therapeutical approach in the treatment of obesity, but use to fail on long terms of time. Addition of anti-obesity drugs allows keeping the weight loss during years and improving obesity-related comorbidities.Methods: This review is an actualisation on efficacy, safety and tolerability of the approved drugs on the long-term treatment of obesity (orlistat and sibutramine). New indications and effects of their use far beyond the weight loss are as well commented. Finally, potential benefits of the administration of CB1 antagonist rimonabant on the weight loss and cardiometabolic risk factors are analysed in detail.Discussion: A decade of experience on the use of orlistat and sibutramine has demonstrated their higher efficacy on the weight loss when compared to placebo either on adult or teenage population as well as safety and tolerability on long-term administration. Beneficial effects on the lipid profile, glycosilated haemoglobin on diabetic patients, blood pressure and levels of inflammatory cytokines, contribute to decrease the cardiovascular risk on obese patients. Phase III clinical trials using rimonabant show additional benefits to the expected weight loss, mainly reducing visceral fat and cardiometabolic risk factors.Conclusion: Pharmacological treatment of obesity must be considered as a therapeutical tool that has to be used together with long-term lifestyle changes, contributing to the body weight reduction as well as to the improvement of the cardiometabolic risk related to obesity. [ABSTRACT FROM AUTHOR]- Published
- 2007
- Full Text
- View/download PDF
50. Adiponectin: An emerging cardiovascular risk factor. The REFERENCE study | Adiponectina, un factor de riesgo cardiovascular emergente. Estudio REFERENCE
- Author
-
Barrios Alonso, V., Gómez-Huelgas, R., Rodríguez, R., Pedro de Pablos Velasco, Madruga, F., Velasco, E., Giménez, R., Rubio, J. M., López, J. A., Toril, J., Ordóñez, A., Yoldi, A., Montagud, J. B., Pinar, J., Fernández, M. L., Gómez, R., Sánchez, A., Martín, J. A., Mateos, L., Díaz, J. A., Suárez, M. A., Saban, J., Arroyo, R., López, J., Fontanals, C., López, A., Marín, R., Chacón, A., Carretero, J. F., Hernández, C., Pérez, L., Villar, M. R., Villar, J. R., Gorgojo, J. J., Barroso, E., Álvarez, P., Campillo, M., Camafort, M., Mazzanti, G., Garre, J., Morales, C., Conde, F. J., Gómez, P., Fernández, F., Suárez, S., Villarroel, M. T., Salgado, F. M., Egido, J., Enjuto, J., Gargallo, M. A., García, J. A., Azcona, L. M., Zamorano, J. L., Candel, I., Serra, V., García, A. M., Luis, D., Romero, E., Guerra, J. M., Gómez, F. J., Fuertes, J., Daniel, C., Gunther, S. J., Bellido, D., Yañez, J. C., Soto, F., Rigueiro, P., García, J. M., Díaz, J. L., Sotres, G., Rondan, J. J., Aziz, A., Barriales, V., Asensio, F., Richard, J. M., García, S., Rodrigo, A., Pérez, J., Ruiz, P., Angel, J., Gascueña, R., Ortiz, R., Rayo, M., Martínez, E., González, O., Ortiz, A., Gómez, L. F., Donnay, S., Melehi, D., Horcajo, P., García, F., Gómez, J., Calderón, A., Fernández, M. C., Pujadas, R., Rafael, J., Alfani, O., Virgos, G., Elsaheb, M., Recio, J., Montull, S., Abardia, X., Sucunza, N., Borrallo, R. M., Palos, M. A., Fernández, L. A., Arribas, J. M., Quintas, L., Camacho, I., Montes, P. M., Novales, J. A., Catalán, J. I., Arteaga, R., Ezcurdia, J., Moreno, C., Morillas, M., García, H., Ribas, M., Ortiz, J., Segura, I., Soler, J., Ripoll, T., Fosch, J., Moreno, R., Domenech, M., Antonio, M. T., Viguera, J., Paytubi, C., Blanch, P., Cuatrecasas, G., Gómez, J. M., Laguna, A., Mayos, J., Lapuebla, M. C., Morales, A., Silva, C., Taberna, S., Cordero, A., Pérez, S., Madariaga, I., Elejalde, J. I., Ancin, R., Tiberio, G., Gracia, M. L., Berdun, M. A., García, A., Gayán, R., Sanz, A., Férriz, P., Piedecausa, M. M., Toral, A., Hernández, E., Carnero, A., Arribas, J., Hernández, A., García, B., Gonzálvez, M., Martínez, T., Mediavilla, J. D., Fernández, C., Romero, J. A., González, A., Fajardo, R., Ramos, E., Aramburu, O., Rivera, F. J., Arias, J. L., Beltrán, J., Melguizo, I., Mateos, P. C., Mendoza, M. E., Romero, S. P., Motero, J., Guevara, J. A., Sánchez, H., Espino, A., Varela, J. M., Lobon, J. A., Jiménez, B., Arizón, J. M., Mora, J., Piñero, I., Gaitán, D., Fernández, D., Carmona, J. R., Garrido, A. M., Gómez, J. J., Costo, A., Alfredo, O., Marcos, G., Porras, Y., Hernández, J., Morales, J., Pérez, J. C., Suárez, M. M., Jiménez, P., and Martínez, F. J.
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.